科技类企业港股上市

Search documents
科技类企业赴港IPO,小心这12个问题
梧桐树下V· 2025-08-09 07:00
Core Viewpoint - The Hong Kong Stock Exchange has introduced a new policy called "Tech Company Special Line," which provides a confidential listing channel and lowers the threshold for specialized technology and biotechnology companies, attracting more tech firms to consider listing in Hong Kong [1]. Group 1: Policy Overview - The new policy aims to facilitate the listing of specialized technology companies (e.g., AI, chips, new energy) and biotechnology companies (e.g., innovative drugs, medical devices), particularly those in early stages or with non-commercialized products [3][4]. - In June 2025 alone, 15 new stocks were listed in Hong Kong, with a peak of five companies listed on the same day in early July, and around 200 applications currently under review [1]. Group 2: Eligibility Criteria - Companies must belong to the categories defined by the Hong Kong Stock Exchange as "specialized technology" or "biotechnology" [3]. - Specialized technology includes fields such as artificial intelligence, quantum computing, new energy, semiconductors, and autonomous driving [3]. - Biotechnology includes innovative drug development, gene therapy, and high-end medical devices [4]. - Companies must have R&D expenditures constituting at least 15% of total costs over the past three years for specialized technology or have core products that have passed Phase I clinical trials for biotechnology [4]. Group 3: Application Process - Companies should first assess their eligibility using the self-assessment tool available on the Hong Kong Stock Exchange website [6]. - If uncertain, they can fill out the inquiry form and send it to the Hong Kong Stock Exchange for preliminary feedback within a week [7]. - The application process involves signing a Non-Disclosure Agreement (NDA) and submitting confidential materials in a specified format [8][10]. Group 4: Review and Feedback - The review team from the Hong Kong Stock Exchange will provide feedback within 30 days, focusing on technical feasibility and compliance [11]. - Companies are advised to provide third-party technical certifications and ensure transparency in related transactions to avoid common pitfalls [17][20]. Group 5: Post-Listing Compliance - After listing, companies must disclose information regarding technological commercialization progress and significant collaborations, while they can apply for exemptions for sensitive details related to national security [22]. - Maintaining market capitalization can be supported by publishing quarterly R&D updates and engaging with analysts regularly [23]. - Companies can utilize a simplified procedure for issuing new shares, allowing for rapid approval [24]. Group 6: Comparative Analysis - The article compares the listing requirements and processes across different markets, highlighting that Hong Kong's "Tech Company Special Line" has no profitability requirement, a shorter review period, and lower disclosure requirements compared to A-shares and U.S. markets [25].